Redrawing the Pharma Investment Map: How Trade and Policy Are Reshaping Capital Flows

Global pharmaceutical manufacturing is being redefined by a new era of trade friction, industrial policy, and strategic decoupling. As governments rethink supply chain security and impose new tariffs and incentives, capital is following a different path – away from traditional hubs and toward regionalised, politically-aligned ecosystems.